The Australian Government is developing a National Preventative Health Strategy (2021-2030) to address the third pillar (prioritising mental health and preventive health) of Australia’s Long Term National Health Plan and align with the 2020-25 National Health Reform Agreement. Australian Genomics’ submission highlighted emerging areas where the application of genomic technologies has real potential to be incorporated in and impact national preventative health strategies, such as reproductive carrier screening, newborn screening and pharmacogenomics.
